Astrazeneca Pharma India Ltd.

ASTRAZEN Share PricePharmaceuticals & Drugs

9,155

8 (0.1%)

As on December 12, 2025

Exchange Scrips: BSE506820NSEASTRAZENISININE203A01020

Market Cap22,888 Cr

P/E Ratio 197.75

Dividend Yield 0.17 %

Performance

Market performance

Open9,100
High9,200
Volumes2,254
Prev9,155
Low9,100
As on2025-12-12

Historical performance

1 Year High10,691
3 Year High10,691
5 Year High10,691
1 Year Low6,312.75
3 Year Low3,098
5 Year Low2,445.7

Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
22,888
Face Value
Face Value (₹)
2
P/E Ratio
P/E Ratio
197.75
Dividend Yield
Dividend Yield
0.17 %

Investment Returns

1 Year
37.7%
3 Years
170.5%
5 Years
103.3%
10 Years
757.5%

Technicals

IndicatorsValueSignal
5-DMA9,077.3Bullish
10-DMA9,114.5Bullish
20-DMA9,084.45Bullish
50-DMA9,207.68Bearish
100-DMA9,018.83Bullish
200-DMA8,760.15Bullish

Shareholding Pattern

FieldSep-2025Jun-2025Mar-2025Dec-2024Sep-2024
Promoters11111
Foreign Investors11111
Domestic Investors---------------
Public Investors3291334377324652732127614
Government---------------

Financials

Below figures are in Rs. Crores

Balance Sheet

Below figures are in Rs. Crores

Cash Flow

Below figures are in Rs. Crores

0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 197.75.
  • 3Y Stock Price CAGR of the stock is 39.3.
  • The stock has a beta of 0.4.
  • In the last financial year, the company had an EBITDA of ₹2946 Million.
  • The company generated revenue of ₹17163 Million in the previous financial year.

Astrazeneca Pharma India Ltd.

91558   (0.1%)

Investment Amount: ₹ 1000000
Current Value: ₹ 1386596
No. of Shares: 151 (Approx)
Performance:38.7%
P/L: ₹386596

Top Gainers

SymbolChange%
MAHAPEXLTD95.24(20%)
VIPULLTD10.24(20%)
TVVISION7.77(20%)
TARIL280.2(17%)
WALCHANNAG175.53(14%)

Top Losers

SymbolChange%
REFEX254.9(-20%)
VLSFINANCE299.45(-10%)
BALAXI30.06(-9%)
VLEGOV21.01(-9%)
KSR17.33(-9%)
ASMS12.2(-8%)
VINNY1.28(-7%)
RAJSREESUG37.79(-6%)

Peer Comparison

Venus Remedies Ltd.

53.5%

825.4

1 Month Performance

Nectar Lifesciences Ltd.

48.7%

21.04

1 Month Performance

SMS Pharmaceuticals Ltd.

11.4%

320.7

1 Month Performance

Natco Pharma Ltd.

10.1%

905.65

1 Month Performance

Haleos Labs Ltd.

9.8%

1386.8

1 Month Performance

Ipca Laboratories Ltd.

9.3%

1465.9

1 Month Performance

Zota Health Care Ltd.

9%

1670.2

1 Month Performance

Emcure Pharmaceuticals Ltd.

7.6%

1438.6

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month